Aligos Therapeutics Inc
(ALGS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 0 | 0 | 70,103 | 24,547 |
| Marketable Securities | 0 | 0 | 0 | 48,098 | 66,817 |
| Other current assets | 0 | 0 | 0 | 2,025 | 1,005 |
| TOTAL | $0 | $0 | $0 | $120,226 | $92,369 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 10,025 | 2,990 |
| Investments And Advances | 0 | 0 | 0 | 10,019 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 188 | 178 |
| TOTAL | $N/A | $N/A | $N/A | $20,232 | $3,168 |
| Total Assets | $0 | $0 | $0 | $146,520 | $107,731 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 3,767 | 2,977 |
| Accrued Expenses | 0 | 0 | 0 | 7,599 | 3,258 |
| TOTAL | $0 | $0 | $0 | $13,818 | $7,489 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 185,714 | 101,380 |
| TOTAL | $N/A | $N/A | $N/A | $185,892 | $101,406 |
| Total Liabilities | $0 | $0 | $0 | $211,411 | $121,479 |
| Shareholders' Equity | |||||
| Retained earnings | 0 | 0 | 0 | -66,197 | -13,933 |
| Other shareholders' equity | 0 | 0 | 0 | -115 | 3 |
| TOTAL | $0 | $0 | $0 | $-64,891 | $-13,748 |
| Total Liabilities And Equity | $0 | $0 | $0 | $146,520 | $107,731 |